[Free Webinar] Maximizing the impact of your scientific poster: TIPS, TRAPS and TOOL

	Drug Discovery
	The latest drug discovery news from News Medical

Whether you're presenting your first or fiftieth poster, creating a clear, engaging poster and making the most of your session are skills that can significantly increase the impact of your research.

Chaired by ELRIG ECP Work Group member Jasmine Trigg, the session offers best practice and practical advice for researchers at every career stage. It will also explore how platforms such as AZoNetwork's Digital Poster Hub can help researchers share their work with a global audience, increasing the visibility and longevity of their research beyond the conference.

Not All Reporters Reveal the Same Biology

Are you evaluating reporter assays? We put together a guide that walks you through key decision points: signal stability, normalization, throughput requirements and what to consider when your target is at the edge of detection. Find the right assays for your experiments.

View All Luciferase Reporter Assays

Advancing Proximity-Based Drug Development

Targeted protein degradation is reshaping drug discovery, from PROTACs to molecular glues and proximity-based approaches. This eBook explores the scientific, technical, and development considerations helping teams identify stronger candidates, improve selectivity, and accelerate therapeutic innovation across complex disease areas where conventional modalities may fall short for patients worldwide today.

Download the Full Event Guide

	Scientists identify new drug target to combat airborne tuberculosis Tuberculosis bacteria released into the air from infected individuals dry out to form infectious particles that are second only to measles in contagiousness.

	New method based on human blood simplifies mRNA drug development mRNA-based drugs are emerging as the drug of the future for a wide range of diseases, but they are difficult and time-consuming to develop.

	Insilico Medicine releases frontier AI models for drug discovery Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced the release of a series of frontier specialist models for chemistry and biology, trained through its MMAI Gym for Science framework.

	New Open-Access Protein Atlas Aims to Streamline Future Drug Development For a new drug to work in the human body, it must make its way to the exact cell type where it's needed and then, in many cases, get inside the cells.

How would you rate today's newsletter?

Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2026